登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002097 证券简称：山河智能 公告编号：2026-005 山河智能装备股份有限公司 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、本次股东会无否决议案的情形； 2、本次股东会无涉及变更以往股东会已通过决议的情形； 3、本次股东会采取现场投票与网络投票表决相结合的方式召开。 一、会议召开情况 山河智能装备股份有限公司（以下简称"公司"）2026年第一次临时股东会（以下简称"本次股东会"）以 现场表决与网络表决相结合的方式召开。 1、本次股东会现场会议于2026年2月26日（星期四）15:30在公司总部大楼405会议室召开。 2、本次股东会网络投票时间为：2026年2月26日，其中： 通过深圳证券交易所交易系统进行网络投票的时间为2026年2月26日9:15一9:25，9:30一11:30 和13:00一 15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为2026年2月26日9:15一15:00 的任意时间。 3、本次会议由公司董事 ...

1、本次股东会无否决议案的情形； 2、本次股东会无涉及变更以往股东会已通过决议的情形； 证券代码：002097 证券简称：山河智能 公告编号：2026-005 山河智能装备股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 3、本次股东会采取现场投票与网络投票表决相结合的方式召开。 一、会议召开情况 山河智能装备股份有限公司（以下简称"公司"）2026 年第一次临时股东 会（以下简称"本次股东会"）以现场表决与网络表决相结合的方式召开。 1、本次股东会现场会议于 2026 年 2 月 26 日（星期四）15:30 在公司总部 大楼 405 会议室召开。 2、本次股东会网络投票时间为：2026 年 2 月 26 日，其中： 通过深圳证券交易所交易系统进行网络投票的时间为2026年2月26日9:15 —9:25，9:30—11:30 和 13:00—15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为 2026 年 2 月 26 日 9:15—15:00 的任意时间。 3、本次会议由公司董事 ...

湖南启元律师事务所 关于 本所律师出具本法律意见书基于公司已作出如下承诺：所有提供给本所律师 的文件的正本以及经本所律师查验与正本保持一致的副本均为真实、完整、可靠。 1、刊登在深圳证券交易所网站（http://www.szse.cn）的与本次股东会有关的通 知等公告事项； 2、出席会议的股东或其代理人的身份证明文件、持股证明文件、授权委托书 等； 3、本次股东会股权登记日的股东名册、出席现场会议的股东的到会登记记录 及相关资料； 为出具本法律意见，本所律师依法审核了公司提供的下列资料： 山河智能装备股份有限公司 2026年第一次临时股东会的 法律意见书 二O二六年二月 致：山河智能装备股份有限公司 湖南启元律师事务所（以下简称"本所"）接受山河智能装备股份有限公司（以 下简称"公司"）的委托，指派本所律师出席了公司 2026 年第一次临时股东会（以 下简称"本次股东会"），对会议进行现场律师见证，并发表本法律意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》、《上市公司股东会规则》（以下简称"《股东会规则》"）等我国 现行法律、法规、规范性文件以及《山河智能装 ...

Group 1 - The company, SANY Heavy Industry Co., Ltd. (stock code: 002097), has recently announced plans for a temporary shareholders' meeting for the first time in 2026, with the specific date yet to be determined [1][2] - To manage risks associated with exchange rate and interest rate fluctuations, the company plans to engage in financial derivative transactions with a limit not exceeding RMB 1 billion for hedging purposes [2][3] Group 2 - The company anticipates a total transaction amount of RMB 1.197 billion with related parties in 2026, covering categories such as procurement of goods, sale of goods, and financing leasing [3]

Key Points - The company reported a closing price of 11.51 yuan on February 6, 2026, with a decrease of 0.86% and a trading volume of 146,700 shares, amounting to a transaction value of 170 million yuan [1] - On the same day, the net outflow of funds from major investors was 12.46 million yuan, while retail investors saw a net inflow of 18.02 million yuan [1] Company Announcements - The company held its fourth meeting of the ninth board of directors on February 4, 2026, where several resolutions were passed, including proposals for expected daily related transactions for 2026, financial derivatives business, and strategic development planning [1][3] - The company plans to hold its first extraordinary general meeting of shareholders on February 26, 2026, to review the proposals related to daily related transactions and financial derivatives business, with a focus on ensuring compliance and proper voting procedures [1][3] Financial Derivatives Business - The company intends to engage in financial derivatives trading to mitigate risks associated with foreign currency settlement and exchange rate fluctuations, with a maximum limit of 1 billion yuan for the trading activities [2][3] - The trading will include various instruments such as forward exchange contracts, currency swaps, options, and interest rate swaps, aimed at hedging rather than speculative purposes [2][3] Related Transactions - The company anticipates a total of 1.1968 billion yuan in daily related transactions for 2026, covering categories such as procurement, labor services, and leasing [4] - The pricing for these related transactions will be based on market prices, and the proposals have been approved by the board, pending shareholder approval [4][5]

Group 1 - The company will hold its first extraordinary general meeting of shareholders in 2026 on February 26, 2026, combining on-site voting and online voting [3][4][47] - The meeting will discuss several proposals, including related party transactions, which require abstention from voting by related shareholders [6][7] - The registration date for shareholders to attend the meeting is set for February 10, 2026 [5] Group 2 - The company plans to engage in financial derivatives business to hedge risks associated with international operations, with a maximum trading amount of RMB 1 billion over the next twelve months [20][22] - The financial derivatives will include products such as forwards, options, swaps, and futures, aimed at mitigating currency and interest rate risks [21][22] - The board of directors has approved the proposal to conduct financial derivatives business, which will be submitted for shareholder approval at the upcoming meeting [46][29] Group 3 - The company anticipates a total of RMB 1,196.8 million in related party transactions for 2026, which will be subject to shareholder approval [32][36] - The related party transactions are necessary for the company's daily operations and are expected to be conducted at fair market prices [37][39] - The independent directors have reviewed and approved the related party transaction proposal, confirming it does not harm the interests of the company or its shareholders [38][39]

Core Viewpoint - The company, Shanhe Intelligent Equipment Co., Ltd., is planning to engage in financial derivatives trading to mitigate foreign exchange and interest rate risks, with a maximum transaction amount of 1 billion RMB, while also forecasting significant related party transactions for 2026 [1][4][3]. Trading Information Summary - As of February 5, 2026, Shanhe Intelligent's stock closed at 11.61 RMB, down 0.6%, with a turnover rate of 1.51%, trading volume of 161,600 shares, and a transaction value of 188 million RMB [1]. - On the same day, the net outflow of main funds was 12.13 million RMB, while retail investors saw a net inflow of 21.45 million RMB [1]. Company Announcement Summary - The company held its fourth meeting of the ninth board of directors on February 4, 2026, where several resolutions were passed, including proposals for expected daily related party transactions for 2026, financial derivatives business, and strategic development planning [1][3]. - The company plans to hold its first extraordinary shareholders' meeting on February 26, 2026, to review the proposals related to daily related party transactions and financial derivatives business, with specific provisions for related shareholders to abstain from voting [1][4]. Financial Derivatives Business Analysis - The company aims to conduct financial derivatives trading to hedge against foreign exchange risks, with a total limit of 1 billion RMB, using its own funds and engaging with qualified domestic and foreign banks [2][3]. - The types of derivatives include forward contracts, currency swaps, options, and interest rate swaps, with a focus on hedging rather than speculative trading [2][3]. Expected Related Party Transactions - The company anticipates a total of 1.1968 billion RMB in related party transactions for 2026, covering various categories such as procurement, labor services, and leasing [4][5]. - The pricing for these transactions will be based on market prices and has been approved by the board, pending shareholder meeting approval [4][5].

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

Core Viewpoint - The company announced plans to engage in financial derivatives business to hedge against risks related to exchange rates and interest rates, pending approval from the upcoming shareholders' meeting [1] Group 1: Business Development - The company will hold its ninth board meeting in 2026 to review the proposal for the financial derivatives business, which will then be submitted for approval at the first extraordinary shareholders' meeting of 2026 [1] - The planned trading amount for the financial derivatives business is expected to not exceed 1 billion yuan within the next 12 months, with the validity period of the trading limit lasting 12 months from the date of shareholder approval [1] - The business will utilize self-owned funds and will include products such as forwards and options [1] Group 2: Risk Management - The primary aim of initiating this business is to mitigate risks associated with fluctuations in exchange rates and interest rates [1] - The company has established corresponding risk control measures to manage the potential risks involved in this new business venture [1]

Group 1 - The company, Shanhe Intelligent, announced that its ninth board meeting was held on February 4, 2026, via teleconference [1] - The meeting reviewed a proposal regarding the initiation of financial derivatives business [1]